Samples were filtered to those with the required features (event-free survival (EFS), age at diagnosis, MYCN amplification and International Neuroblastoma Staging System (INSS) stage) and only genes present in all datasets were used (n = 35). This evidence concerns the gene MYCN and neuroblastoma.